Lustigman S - Search Results

1

rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens.

MacDonald AJ, Cao L, He Y, Zhao Q, Jiang S, Lustigman S. MacDonald AJ, et al. Among authors: lustigman s. Vaccine. 2005 May 16;23(26):3446-52. doi: 10.1016/j.vaccine.2005.01.098. Vaccine. 2005. PMID: 15837368 Free PMC article.

2

Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.

MacDonald AJ, Turaga PS, Harmon-Brown C, Tierney TJ, Bennett KE, McCarthy MC, Simonek SC, Enyong PA, Moukatte DW, Lustigman S. MacDonald AJ, et al. Among authors: lustigman s. Infect Immun. 2002 Jun;70(6):2796-804. doi: 10.1128/IAI.70.6.2796-2804.2002. Infect Immun. 2002. PMID: 12010965 Free PMC article.

3

CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.

Lustigman S, MacDonald AJ, Abraham D. Lustigman S, et al. Int J Parasitol. 2003 Sep 30;33(11):1161-71. doi: 10.1016/s0020-7519(03)00170-x. Int J Parasitol. 2003. PMID: 13678632 Review.

4

Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.

MacDonald AJ, Tawe W, Leon O, Cao L, Liu J, Oksov Y, Abraham D, Lustigman S. MacDonald AJ, et al. Among authors: lustigman s. Parasite Immunol. 2004 Jan;26(1):53-62. doi: 10.1111/j.0141-9838.2004.00685.x. Parasite Immunol. 2004. PMID: 15198646 Free article.

5

Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.

He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S. He Y, et al. Among authors: lustigman s. J Immunol. 2006 May 15;176(10):6085-92. doi: 10.4049/jimmunol.176.10.6085. J Immunol. 2006. PMID: 16670317

6

Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.

He Y, Li J, Heck S, Lustigman S, Jiang S. He Y, et al. Among authors: lustigman s. J Virol. 2006 Jun;80(12):5757-67. doi: 10.1128/JVI.00083-06. J Virol. 2006. PMID: 16731915 Free PMC article.

7

A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action.

MacDonald AJ, Libri NA, Lustigman S, Barker SJ, Whelan MA, Semper AE, Rosenberg WM. MacDonald AJ, et al. Among authors: lustigman s. Clin Exp Immunol. 2008 May;152(2):265-73. doi: 10.1111/j.1365-2249.2008.03623.x. Epub 2008 Mar 12. Clin Exp Immunol. 2008. PMID: 18341617 Free PMC article.

8

Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.

Xiao W, Du L, Liang C, Guan J, Jiang S, Lustigman S, He Y, Zhou Y. Xiao W, et al. Among authors: lustigman s. Vaccine. 2008 Sep 15;26(39):5022-9. doi: 10.1016/j.vaccine.2008.07.028. Epub 2008 Aug 19. Vaccine. 2008. PMID: 18675867 Free PMC article.

9

Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells.

He Y, Barker SJ, MacDonald AJ, Yu Y, Cao L, Li J, Parhar R, Heck S, Hartmann S, Golenbock DT, Jiang S, Libri NA, Semper AE, Rosenberg WM, Lustigman S. He Y, et al. Among authors: lustigman s. J Immunol. 2009 Apr 1;182(7):4005-16. doi: 10.4049/jimmunol.0800531. J Immunol. 2009. PMID: 19299698

10

Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant.

Zhao G, Du L, Xiao W, Sun S, Lin Y, Chen M, Kou Z, He Y, Lustigman S, Jiang S, Zheng BJ, Zhou Y. Zhao G, et al. Among authors: lustigman s. Vaccine. 2010 Oct 18;28(44):7233-40. doi: 10.1016/j.vaccine.2010.08.049. Epub 2010 Aug 21. Vaccine. 2010. PMID: 20732469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters